AAAAAA

   
Results: 1-13 |
Results: 13
EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN MAN
Authors: FUDER H STIEGLER S WETZELSBERGER N WIECKHORST G LANGE R LUCKER PW
Citation: H. Fuder et al., EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN MAN, British journal of clinical pharmacology, 44(6), 1997, pp. 527-530
THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT CHANGE PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN
Authors: FUDER H KLEIST P BIRKEL M EHRLICH A EMEKLIBAS S MASLAK W STRIDDE E WETZELSBERGER N WIECKHORST G LUCKER PW
Citation: H. Fuder et al., THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT CHANGE PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 153-157
PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION
Authors: FUDER H HARTMANN M WIECKHORST G EHRLICH A TIMMER W LUHMANN R WURST W
Citation: H. Fuder et al., PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION, Gut, 41, 1997, pp. 97-97
PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION
Authors: FUDER H HARTMANN M WIECKHORST G EHRLICH A TIMMER W LUHMANN R WURST W
Citation: H. Fuder et al., PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION, Gastroenterology, 112(4), 1997, pp. 119-119
PANTOPRAZOLE ONCE-DAILY VERSUS TWICE-DAILY - A PH-METRY STUDY
Authors: FUDER H EHRLICH A WIECKHORST G LUCKER PW CAIN CR
Citation: H. Fuder et al., PANTOPRAZOLE ONCE-DAILY VERSUS TWICE-DAILY - A PH-METRY STUDY, Gastroenterology, 112(4), 1997, pp. 120-120
VOGLIBOSE DOES NOT MODIFY PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN IN HEALTHY MAN
Authors: FUDER H KLEIST P STRIDDE E EHRLICH A EMEKLIBAS S MASLAK W WIECKHORST G BIRKEL M WETZELSBERGER N
Citation: H. Fuder et al., VOGLIBOSE DOES NOT MODIFY PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN IN HEALTHY MAN, Diabetologia, 40, 1997, pp. 1210-1210
LACK OF PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTION BETWEEN PANTOPRAZOLE AND PHENPROCOUMON IN MAN
Authors: EHRLICH A FUDER H HARTMANN M WIECKHORST G TIMMER W HUBER R BIRKEL M BLIESATH H STEINIJANS VW WURST W LUCKER PW
Citation: A. Ehrlich et al., LACK OF PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTION BETWEEN PANTOPRAZOLE AND PHENPROCOUMON IN MAN, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 277-281
EFFECT OF 4 LANSOPRAZOLE DOSE LEVELS AND ONE DOSAGE REGIMEN OF OMEPRAZOLE ON 24-HOUR INTRAGASTRIC PH IN HEALTHY-SUBJECTS
Authors: TIMMER W RIPKE H KLEIST P EHRLICH A WIECKHORST G LUCKER PW FUDER H
Citation: W. Timmer et al., EFFECT OF 4 LANSOPRAZOLE DOSE LEVELS AND ONE DOSAGE REGIMEN OF OMEPRAZOLE ON 24-HOUR INTRAGASTRIC PH IN HEALTHY-SUBJECTS, Methods and findings in experimental and clinical pharmacology, 17(7), 1995, pp. 489-495
1ST ADMINISTRATION TO MAN OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR-BY841 - TOLERABILITY, SAFETY AND PH-METRY
Authors: FUDER H HARTMANN M TIMMER W LUHMANN R WIECKHORST G HUBER R BLIESATH H WURST W POSTIUS S RADTKE HW LUCKER PW
Citation: H. Fuder et al., 1ST ADMINISTRATION TO MAN OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR-BY841 - TOLERABILITY, SAFETY AND PH-METRY, Gastroenterology, 108(4), 1995, pp. 96-96
VOGLIBOSE (AO-128) IS AN EFFICIENT ALPHA-GLUCOSIDASE INHIBITOR AND MOBILIZES THE ENDOGENOUS GLP-1 RESERVE
Authors: GOKE B FUDER H WIECKHORST G THEISS U STRIDDE E LITTKE T KLEIST P ARNOLD R LUCKER PW
Citation: B. Goke et al., VOGLIBOSE (AO-128) IS AN EFFICIENT ALPHA-GLUCOSIDASE INHIBITOR AND MOBILIZES THE ENDOGENOUS GLP-1 RESERVE, Digestion, 56(6), 1995, pp. 493-501
INVESTIGATION INTO A POSSIBLE DRUG-DRUG INTERACTION BETWEEN WARFARIN AND NIMESULIDE IN HEALTHY-VOLUNTEERS
Authors: THEISS U TIMMER W WIECKHORST G MACCIOCCHI A WETZELSBERGER N
Citation: U. Theiss et al., INVESTIGATION INTO A POSSIBLE DRUG-DRUG INTERACTION BETWEEN WARFARIN AND NIMESULIDE IN HEALTHY-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 15(9), 1993, pp. 629-635
RENAL ELIMINATION OF MAGNESIUM AS A PARAMETER OF BIOAVAILABILITY OF ORAL MAGNESIUM THERAPY (VOL 14, PG 269, 1992)
Authors: KUHN I JOST V WIECKHORST G THEISS U LUCKER PW
Citation: I. Kuhn et al., RENAL ELIMINATION OF MAGNESIUM AS A PARAMETER OF BIOAVAILABILITY OF ORAL MAGNESIUM THERAPY (VOL 14, PG 269, 1992), Methods and findings in experimental and clinical pharmacology, 15(5), 1993, pp. 329-329
COMPARISON OF THE 24H INTRAGASTRIC PH PROFILES FOLLOWING SINGLE AND REPEATED ORAL INTAKE OF PANTOPRAZOLE 40MG AND OMEPRAZOLE 20MG IN HEALTHY MALE-VOLUNTEERS
Authors: HARTMANN M THIESS U BLIESATH H WIECKHORST G LUHMANN R HUBER R WURST W POSTIUS S LUCKER PW
Citation: M. Hartmann et al., COMPARISON OF THE 24H INTRAGASTRIC PH PROFILES FOLLOWING SINGLE AND REPEATED ORAL INTAKE OF PANTOPRAZOLE 40MG AND OMEPRAZOLE 20MG IN HEALTHY MALE-VOLUNTEERS, Gastroenterology, 104(4), 1993, pp. 95-95
Risultati: 1-13 |